Surgical Tourniquets Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2031

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 481 million in 2022, up from ~US$ 444.5 million in 2021, according to the latest research from Future Market Insights (FMI).

FMI’ analysis expects the surgical tourniquets market to grow at ~7.8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

Sales of Tourniquet Cuffs to Ramp up in 2022

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2021. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2021, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2022.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2254

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2021, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2021. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2254

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Cotinine Screening Devices Market Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031

According to a new market research report by Future Market Insights, the global cotinine screening devices market was valued at ~US$ 429.9 Mn in 2021, and is expected to increase at a CAGR of ~4.7% during the forecast period of 2022-2029. The report scrutinizes the cotinine screening devices market and provides critical insights for the forecast period of 2022-2029. As per the findings of the report, the global cotinine screening devices market is projected to experience a significant growth over the forecast period, which will be set in motion by a slew of factors such as growing focus on ‘value-driven’ healthcare services and high demand for effective screening techniques.

Developing Markets to Reflect New Growth Possibilities

Regions such as North America and Europe are expected to hold prominent market share in terms of value. However, developing markets are expected to project lucrative growth in the global cotinine screening devices market in the forecast period of 2022-2029. The exponential rise in workplace screening is one of the key drivers laying new growth alleys for manufacturers of cotinine screening devices to reap benefits from. The economic and technological parity of developing regions with the developed ones is another chief factor estimated to generate steady sales revenue for market players of cotinine screening devices.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8472

Furthermore, rising level of awareness and adoption of products useful in smoking cessation programs is further upholding the lucrativeness of developing markets such as China, India and Brazil. The factors such as growing prevalence of smoking, screening employees for illicit drugs, sporting events, and deciding the health plan premium are anticipated to surge the sales of cotinine screening devices in developing counties.

The burgeoning middle-class population along with multiple compliances created for recruitment in the armed forces are anticipated to increase the potential use cases of cotinine screening devices in 2022 and beyond. The contract manufacturing services available in developing markets coupled with cheap labor force are expected to boost the investment and attractiveness quotient of developing countries, making them no less than hotbeds of opportunities for growth.

End Users to Show Marked Preferences for Cassettes

By device type, the cassettes are expected to hold prominent value shares of the global cotinine screening devices market. This has majorly resulted from the cost effectiveness, ease of screening, quick detection, and portability of these compact cotinine screening devices. The report features the prominent players in the cotinine screening devices market, whose success has been riding on their strong portfolios and regional presence.

The global cotinine screening devices market is significantly consolidated with a chunk of players commanding prominent shares of the market. These players are offering cotinine screening devices under their popular brands such as Accutest®, ALERE ISCREEN®, Reditest®, QuickProfile™, NicCheck™ I, DrugCheck® SalivaScan™, TobacAlert®, among others.  Mergers and acquisitions will remain one of the key part of the growth & expansion strategies of cotinine screening devices market players, with an extensive emphasis on creating newer business models as well as distribution channels.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8472

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Tissue Engineered Skin Substitute Market Trend 2021, Growth, Leading Companies with Impact of Covid-19, Business Scenario, Emerging Dynamics, Industry Share and Revenue Forecast by 2031

Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-781

Key Takeaways – Tissue Engineered Skin Substitute Market Study

  • With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
  • Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
  • The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-781

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Implantable Drug Eluting Devices Market 2021 (COVID-19 Impact Analysis Included) Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2031

Implantable drug-eluting devices are playing a key role in the management and treatment of various chronic disorders, particularly cardiovascular diseases. Advancements in micro and nanotechnology are aiding key manufacturers to design novel implantable drug-eluting devices.

Moreover, controlled and site-specific attributes of implantable drug-eluting devices, further complemented by compatibility with the targeted drug delivery, are relieving the burden of complex dosing schedule and systemic toxicity of conventional drug delivery system. The global implantable drug-eluting devices market is projected to cross the US$ 10 Bn mark towards the end of 2022. Market leaders in implantable drug-eluting devices landscape are maintaining their focus on refining manufacturing processes.

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices

Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off.

Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with controlled workflow system, plays an effective role in reducing or eliminate the use of oral opioids.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10671

Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention

In July 2022, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implant as a promising approach for HIV treatment.

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the implantable drug-eluting devices market has led our analysts to conclude that, the market is expected to grow with an impressive rate. This market growth is mainly attributed due to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in global implantable drug-eluting devices landscape. To cater to rising demand for implantable drug-eluting devices, medical device companies are collaborating with pharmaceutical companies for the development of efficient drug delivery devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. Introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10671

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Intelligent Enterprise Data Capture Software Market 2022 Development Status, Competition Analysis, Type and Application 2029

The global intelligent enterprise data capture software market is likely to record a total incremental opportunity of ~US$ 21.1 Bn during the forecast period of 2022 to 2029. In the global intelligent enterprise data capture software market report, FMI has segmented the global intelligent enterprise data capture software market by product type, deployment, line of business, industries, and region.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9098

Future Market Insights (FMI) has recently published a market research report, titled “Intelligent Enterprise Data Capture Software Market – Global Industry Analysis 2014 – 2021 and Opportunity Assessment 2022 – 2029.” Intelligent enterprise data capture software takes control and accumulates a large volume of structured, semi-structured, and unstructured data. Intelligent enterprise data capture software enables the rapid transformation of critical business documents into business process-ready digital content by using advanced recognition technology. Intelligence enterprise data capture software uses various technologies to capture all kinds of data such as texts, pictures, printed documents, and several others.

intelligent enterprise data capture software market

Growth of Enterprise Application Realm Favoring Adoption

Digitisation of industries across the globe is increasing. Companies are moving from traditional manufacturing to digital manufacturing and adopting advanced technologies. Increase in investments in industrial IoT technology will bring about a significant change in the near future. Intelligent enterprise data capture software plays a crucial role in industrial automation. Manufacturing, construction, and other industries have witnessed the rapid adoption of advanced technologies. These factors are positively impacting the intelligent enterprise data capture software market. Due to the growth of industrialisation, the overall enterprise application market has witnessed significant growth in the past couple of years. This is expected to have a cascading effect on the intelligent enterprise data capture software market.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9098

Intelligent enterprise data capture software uses different types of technologies such as optical character recognition, intelligent document recognition, and handwriting recognition. Optical character recognition technology is used to convert different types of machine-printed documents, such as image files, PDF files, or scanned paper documents, into searchable and editable data. Intelligent document recognition technology helps recognise and capture handwritten printed characters from image files. Handwriting recognition is the ability of a mobile device or a computer to take as input handwriting from sources such as printed physical documents, pictures and other devices, or to use handwriting as a direct input to a touchscreen and then interpret this as text.

SMEs Emerging as Lucrative Targets for Investors

Advancements in the retail industry have revolutionised the adoption of intelligent enterprise data capture software components in various developing as well as developed regions. To meet the growing demand for error reduction and improved accuracy in the East Asia and South Asia regions, several intelligent enterprise data capture software platform providers have started investing in these regions. The established as well as growing intelligent enterprise data capture software platform providers should focus on expanding their intelligent enterprise data capture software businesses across untapped developing country markets to enhance their global intelligent enterprise data capture software market share.

In addition, it has been observed that growing companies from various sectors are investing significantly on next generation data management solutions and business analytics platforms. Across the world, a growing number of small and medium enterprises are becoming prominent targets for the providers of intelligent enterprise data capture software. Hence, East Asian and South Asian markets are creating new business models for intelligent enterprise data capture software platform providers.

Competition Insights

Key players are focusing on increasing their market shares in the intelligent enterprise data capture software market by entering into joint ventures and strategic partnerships with regional players. In addition, major intelligent enterprise data capture software market players are also expanding their global presence via strategic mergers and acquisitions. Some of the key players in the global intelligent enterprise data capture software market research report include Microsoft Corporation, SAP SE, IBM Corporation, OpenText Corporation, Oracle Corporation, Hyland Software, Inc., Box, Newgen Software Technologies Limited, M-Files, Oracle Corporation, and Nuxeo.

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/9098

Key Questions Answered in the Report

  • What will be the CAGR for the intelligent enterprise data capture software market?

Contact Us:                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Transcutaneous Monitors Market Size Estimates and Forecasts by Region, Growth Rate and Trend Analysis by Types and Application 2021 to 2031

Due to the technological advancement in multichannel monitors, demand for multipara, multichannel transcutaneous monitors is increasing day by day. Despite channel limitations and lack of technological advancements, single channel transcutaneous monitors are likely to garner significant traction in developing countries, in the view of relatively large difference in price as compared to multi-channel transcutaneous monitors.

Multichannel Transcutaneous Monitors to Show Higher Opportunities for New Players

In recent years, the transcutaneous monitors market has been witnessing significant growth, on the back of wide availability of advanced and multi-channel transcutaneous monitors for patient monitoring. The multi-channel transcutaneous monitors involves simultaneous measurement of the ECG, brain functioning, blood gas measurement, and hemoglobin level. Due to rising demand for technologically advanced medical devices, healthcare professionals are giving more priority to buy multichannel transcutaneous monitors. As compared to single-channel transcutaneous monitors, multichannel transcutaneous monitors are fast and provide accurate results. Companies, in the transcutaneous monitors market, are launching products with longer battery life and benchtop portability. Such factors are thus expected to enhance the growth of the transcutaneous monitors market in coming years.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-4980

Market Players to Make Two-Fold Investments in APAC  

The APAC region has more demand for the transcutaneous monitors, due to growing number of hospitals and rising regional government initiatives towards public healthcare program. In the APAC region, South Asian countries including India have more number of hospitals. The mounting number of hospitals is expected to create additional demand for transcutaneous monitors in the future. In addition, growing number of local market players operating in countries such as China is expected to intensify the competition in the transcutaneous monitors market in the coming years.

The transcutaneous monitors market is expected to continue sustaining high demand for multichannel transcutaneous monitors, finds the report. As per FMI’s study, significant sales opportunities for the transcutaneous monitors market players are expected in the APAC & Latin America, owing to robust development in healthcare sectors along with favorable government policies for reduced cost of treatment. Also, there are opportunities in the APAC transcutaneous monitors market for new players, including tax exemption for the first three years.

FMI completed a deep study on transcutaneous monitors by keeping the breadline view in mind about the market CAGR and value share analysis. During the transcutaneous monitors market study, we also studied the top manufacturers’ differential strategies & supply chain parameters. The giant players such as Masimo & Danaher Corporation are focusing on enhancing their product portfolios through the launch of new technology in the transcutaneous monitors market and patented technology in the patient monitoring field. These developmental activities implemented by the top players will remain key to gaining distinct competitive edge in the market.

According to the report, the manufacturer are targeted towards innovations in the continuous patient monitoring field. Some innovations include the overnight patient transcutaneous gas monitors and auto-sleep mode patient monitors. They are the latest monitors with longer battery life and wireless capacity. Some monitors can further work on the smartphone-based application which can help monitor remote-based patients. For the neonate’s care, companies are launching the transcutaneous monitors with gold plated sensors compatibility and better accuracy.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-4980

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

CRISPR Genomic Cure Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2031

According to the latest research by Future Market Insights, the CRISPR Genomic Cure market will undergo a steady growth during 2021-2031.

A gradual increase due to constant research studies being conducted and new verticals of disease treatment being opening can be seen over the mentioned forecast period.

The increasing innovations and advancements in genetic engineering will further boost the market

What is Driving Demand for CRISPR Genomic Cure market

The gene-editing tool which was discovered only about 7 years ago, has shown potential to be used in treating wide-range of diseases like cancer, HIV as well as haematological ailments.

n a news article namely,” Quest to use CRISPR against disease gains ground” published in Nature , a 2016 research done in China where CRISPR was used to disable a specific gene which has the ability to shield cancerous cells from the immune system.

Another potential application of this tool is in treating HIV AIDS. The HIV virus sits in the DNA of the immune cells, so, by using CRISPR we can attack it in its inactive form and kill it in its dormant sate.

This will possibly assist in curing the disease. CRISPR’s potential application in gene-editing and opening avenues for curing otherwise incurable diseases is what will make this market achieve a drastic boost by increasing its demand.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13911

CRISPR and COVID19

While many screening tests are in existence which allow rapid detection of COVID19, recent developments in genetic research shows a possible use of gene-editing in fight the virus.

Study done at Stanford University have developed a technique to destroy the base genetic material of the COVID19 virus, thus preventing from affecting the human lungs.

Results of this study came back very promising, reducing 90% of viral load in the human cells.

Looking at the current scenario, this virus is mutating continuously and making it difficult to find a definite cure.

Therefore, CRISPR technology seems to be taking its steps in the right direction and giving the CRIPSR Genomic Cure market a bright future.

U.S. and Canada CRISPR Genomic Cure market –

US leading the CRISPR Genomic Cure market can be attributed to continuous encouragement for the researchers in doing gene-related research, cancer and rare disease research in the form of strong financial support.

For instance, Leber congenital amaurosis is the most common type of blindness in children which has no treatment as of now.

But, a leading brand in genetic technologies, Editas Medicine Inc., is working on a CRISPR therapy where the respective cells will be edited on a genetic level to restore their function before a child loses the sight completely.

Europe CRISPR Genomic Cure market –

Sickle Cell Disease, which is a genetic disease has one of the most common prevalence in Europe and it has affected over 52,000 people, says the data published by Global Blood Therapeutics Inc.

in October 2020. Gene responsible for haemoglobin production which is present in the stem cell of bone marrow get mutated.  Pertaining to this researchers are exploring new verticals to improve these numbers.

Take the example of Institute Imagine located in Paris. Scientists there have been successful in extracting and treating the faulty genes from the stem cells and insert them inside the human body again which alleviates the symptoms.

This is a breakthrough in curing the diseases by the means of genomics which will provide the necessary boost to the market.

Who are the key Manufacturing and Supplying Companies in CRISPR Genomic Cure Market

Key players:

  • Intellia Therapeutics, Inc.
  • Caribou Biosciences, Inc.
  • CRISPR Therapeutics
  • Editas Medicine, Inc.
  • Casebia Therapeutics
  • ERS Genomics
  • Toolgen Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13911

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Fluid transfer solutions Market Analysis by Growth, segmentation, performance, Competitive Strategies and Forecast to 2031

According to the latest research by Future Market Insights, the Fluid transfer solutions market is set to witness a growth of 5% and 7% during 2021-2031.

Fluid transfer process is considered one of the critical steps in manufacturing processes and takes place routinely in the field of medical, biopharmaceutical or cell therapy industries.

As it involves careful transfer of fluids under sterile conditions, different types of fluid transfer can be achieved on the basis on intended applications and the industry where it is used. Demand for Fluid transfer solutions is expected to witness an optimistic growth outlook in the long run.

What is Driving the Demand for Fluid Transfer Solutions Market

Continuous research activities for the development of newer treatments, growth in pharmaceutical industry producing new vaccines and cell and gene therapy processing industries can be seen using the aseptic transfer of materials in their processes, from small scale to large scale, thus driving the demand for fluid transfer solutions market.

Aseptic transfer of cell and fluid material requires different equipment or devices depending on various product and processes, and as per the industry.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13902

On the basis of this, there are single-use or disposable fluid transfer products and customized fluid transfer products offered by different companies, made of different material such as poly vinyl chloride (PVC) or silicone or stainless steel.

Application of Fluid transfer solutions varies as per the industry such as in medical industry- Poly Vinyl Chloride (PVC) are used for tubing purpose such as in blood bags, IV and fluid transfer sets, dialysis bags and IV containers. While in biopharmaceutical industry, applications includes single use systems, peristaltic pumps, upstream and downstream and fill and finish processes.

Benefits from single use fluid transfer systems can be seen in terms of facility design, validation and investment along with reduced risk of cross contamination, faster turn-around time and improved process connectivity.

The single use systems are thus considered to be driving the market for fluid transfer solutions in the forecast period.

Which Factors are likely to Augment the Growth of the Fluid Transfer Solutions Market

The wide range of fluid transfer products from simple tubing to complex mixing solutions available in the market is expected to augment the growth of fluid transfer solutions market during the forecast period.

This includes single use systems (for sampling, small volume transfer tubes), custom sampling solutions, various filtration and transferring assemblies, multibag mixing systems and bottle manifolds.

Continuous focus on development of innovative approaches to handle fluid solutions, increased level of automation and commercialization of new technologies are being undertaken by many companies serving this field.

This will lead to the growth of the market in the forecast period.

North America Fluid Transfer Solutions Market Outlook

North America market growth is largely driven by advanced healthcare infrastructure and growing healthcare driven research and development.

As per the recent report by National Institutes of Health (NIH), the NIH invests nearly $41 Bn in the field of medical research annually, more than 80% of which is funded to the research institutions and medical schools, while the rest support independent projects in USA.

Investment pertaining to clinical researches in medical industry by many private and government organization have been increased in recent times.

Thereby growing the demand for aseptic transfer of materials and drugs under sterile conditions, which is likely to boost the fluid transfer solutions market in this region during the forecast period.

Europe Demand Outlook for Fluid Transfer Solutions

Europe is anticipated to be the second largest market for fluid transfer solutions.

Growing research and development activities to develop better treatment, new and improved vaccines, leading to innovative aseptic fluid handling approaches and products and the presence of key market players, in the European region will facilitate the growth of the market in the forecasted period.

Who are the key Manufacturers and Suppliers of the Fluid Transfer Solutions

Some of the key players of Fluid transfer solutions include

  • Thermo Fisher Scientific
  • Charter Medical
  • Watson Marlow Fluid Technology Group,
  • Avantor Inc
  • DuPont
  • Saint-Gobain Performance Plastics
  • Cellon

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13902

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Zellweger Spectrum Disorder Market Size, Growth Opportunities, Industry Potential, Segmentation Overview, Trends And Forecast Studies 2031

According to the latest research by Future Market Insights, the Zellweger Spectrum Disorder market will witness growth during 2021-2031.

Zellweger spectrum disorder consists of Heimler Syndrome, Infantile Refsum Disease and Neonatal Adrenoleukodystrophy. With new advances coming up in genomics, novel ways to treat and manage ZSD in a way that gives the minimum discomfort to the victims of this disorder are being researched and trialled.

These will further boost the market during the forecast period.

Being a rare disease, not much was known about ZSD. But now with soaring research investments, better clinical understanding is beginning to build.

This will boost early diagnosis of the disorder which help in mapping appropriate treatment plans. Ultimately, all of these factors will amount to a global market growth.

What is Driving Demand for Zellweger Spectrum Disorder Market

Zellweger spectrum disorders is group of inherited autosomal genetic conditions where most of the organs of the human body are affected.

This disease happens due to mutation of a specific gene called as PEX-gene which makes it defective, showing early signs like high forehead, muscular hypotonia, seizures, vision and hearing difficulties, etc. soon after birth. Therefore, the rising genomics research an important factor to boost its market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13942

This disorder is pretty rare as 1 in 50,000 new-borns get affected due to ZSD.

The novel corona virus has swept the entire globe and hence in finding a cure against it has boosted the research and development faction.

Aggressive research in finding answers towards the previously less researched and rare diseases like zellweger spectrum disorder is gaining popularity as healthcare professionals are wanting to be entirely prepared for any similar occurrence in the future. Making it one of the most important driving factors which will contribute in its growth.

Genetic Counselling for Zellweger Spectrum Disorders

“At birth, there is 25% chance of the sibling of new-born getting affected and 50% chance of that individual being a carrier with no symptoms and 25% chance of being asymptomatic and not a carrier.” says the study done by University of Washington. So, pertaining to this, testing of relatives of the identified affected individual can be undertaken.

Also counselling of these probable carrier individuals to do a prenatal DNA testing in order to plan a timely management of zellweger spectrum disorders can be done.

As, prevalence of this disorder cannot be avoided. Early detection of this disorder will certainly help in early treatment and thus boosting the market.

U.S. and Canada Zellweger Spectrum Disorder Market 

With state-of-the-art healthcare as well as ceaseless researches going on foreshadows that U.S will dominate the North American market.

Presence of a mandate for zellweger screening test for new-born babies added to availability of highly developed diagnostic equipments will aid U.S in dominating the zellweger spectrum disorder market.

Rising initiatives for detection, prevention and treatment of this disorders is helping in boosting the awareness of this disorder.

Europe Zellweger Spectrum Disorder Market 

The second dominant market in zellweger spectrum disorders will be Europe. New-born testing for ZSD is taking a grip after US making it mandatory.

Dedicated research with various collaborations are also underway in order to ensure proper testing facilities and kits are available for the new-born testing and various other verticals for management of this disorder.

Furthermore, presence of players in like Centogene N V (Germany), Asper Biogene LLC (Estonia). in the region is likely to augment ZSD market growth.

Who are the key Manufacturing and Supplying Companies in Zellweger Spectrum Disorder Market

Key Players:

  • Invitae
  • Blueprint Genetics Oy
  • Centogene N V
  • Gene Dx Inc.
  • Asper Biogene LLC
  • Eugene labs
  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13942

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Repositioning and Offloading Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2031

According to the latest research by Future Market Insights, the Repositioning and Offloading Market is set to experience ~4% (CAGR) growth during the year 2021-2031.

The growth of the repositioning and offloading market is attributed due to the increase in the prevalence of obesity, diabetes, and cardiovascular disease, ischemia and reperfusion injury to tissues, impaired lymphatic drainage, spinal injury, and musculoskeletal disorders.

What is Driving Demand for Repositioning and Offloading Market

Pressure ulcer was considered to be one of the costliest and the most physically debilitating complications.

A large patient pool seeking medical help across the globe. In addition to that, rising healthcare expenditure in the developing economies, as well as increasing awareness campaigns regarding the availability of various treatment options, would fuel.

Repositioning and offloading is an acceptable technique for pressure ulcer prevention, is an individual’s shift of posture, by itself or aided (with or without the use of technology or equipment).

Repositioning and offloading minimize or ease the strain on the region at danger, preserve muscle mass and the general integrity of the tissue and provide a sufficient blood supply to the area at risk.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13939

How and With What Frequency Repositioning and Offloading to Avoid Pressure Ulcers Should be Carried Out

Pressure ulcer therapy is based upon the repositioning and offloading pressure source, appropriate drainage of any areas of infection, debriding, and frequent wound treatment to maintain the cure.

Repositioning and offloading frequency are determined based on tissue tolerance, level of activity and mobility, general medical condition, overall treatment objectives, skin condition, and comfort.

This implies rigorous compliance with the patient’s frequent repositioning for bedridden patients. If it is not currently in use, all techniques for supporting the pressure ulcer region should be established.

In addition to regular Onlays and pads, certain patients may need customized beds to help reduce pressure. Typically, these beds employ air to change pressure points continuously using several techniques.

Patients still require constant repositioning, even with modern beds. They may need to go without them for a while to allow a cure for people who take prosthetics.

Any patient who develops a surgical pressure ulcer should be contoured after healing to prevent himself from future difficulties. Patients with a wheelchair may have to have limited movement to permit recovery.

The wheelchair should be checked for its correct fit as with a prosthetic.

The U.S. Repositioning and Offloading Market Outlook

U.S. is expected to have the highest share and therefore will dominate the repositioning and offloading market. In the U.S.,s the fastest growing sector of our population is above the age of 65, and obesity, diabetes, and cardiovascular disease rates are increasing.

This combination of circumstances led to more persons needing support for day-to-day life tasks because of reduced mobility.

The formation of a pressure ulcer is major morbidity to diminished mobility. The treatment of pressure ulcers is long and costs the healthcare system a considerable financial burden.

An estimated $11 billion is spent each year on pressure ulcers in the United States, with $500 to $70,000 spent on a single injury. No one has proven a substantial benefit over the other despite a variety of novel dressings and therapies to handle pressure ulcers.

The major characteristics of the therapy remain the idea of keeping the injured clean and sophisticated.

Repositioning and offloading devices are novel treatments ways to reduce occurrence among sensitive patients with the lowest expenditures.

Europe Demand Outlook for Repositioning and Offloading Market Outlook

The pressure ulcer treatment market has been evolving at a rapid pace in recent years, with companies adapting according to the changing technological trends in developed regions of Europe.

Technological advancements in wound care devices such as repositioning and offloading are projected to have a positive impact on pressure ulcers treatment.

Growing research and development activities to develop innovative devices, the presence of key market players, and growing population acceptance of novel technologies are expected to boost the growth of repositioning and offloading the Market in Europe during the forecast period.

Who are the Key Manufacturers and Suppliers of Repositioning and Offloading Market

Some of the key players operating in the Repositioning and Offloading Market are

  • Stryker (Sage Products)
  • Mölnlycke Health Care AB.
  • Span America
  • 3M Company
  • Felgains Limited,
  • HoverTech International
  • AliMed

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13939

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com